Our study suggested that LINC02086 exhibited oncogenic activities in breast cancer, as evidenced by decreased cell viability, strengthened cell apoptosis and suppressed tumor growth as results from LINC02086 knockdown. Here, LINC02086 is linked to breast cancer.